ANDREA-LD; Anti-psychotic drug reduction in primary care for adults with Learning disabilities

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-000389-12

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The principle objective is to evaluate the impact of a 6-month anti-psychotic medication withdrawal programme where neither the precribing GP nor the patient know which group they are in - the medication reduction group or the treatment as normal group.


Critère d'inclusion

  • Aggression and challenging behaviour in adults with learning disabilities